Original Research

Published on 09 Nov 2022

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer

in Cancer Genetics and Oncogenomics

Yuchen Jin
Xian Qiu
Ziyan He
JunYao Wang
Ri Sa
Libo Chen

Frontiers in Genetics

doi 10.3389/fgene.2022.966365

2,059 views
6 citations

Systematic Review

Published on 09 Nov 2022

Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials

in Cancer Genetics and Oncogenomics

Shuting Chen
Qinchao Hu
Xiaoan Tao
Juan Xia
Tong Wu
Bin Cheng
Juan Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.1065320

7,200 views
13 citations

Original Research

Published on 08 Nov 2022

Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer

in Cancer Genetics and Oncogenomics

Wenwen Zhang
Tianbo Liu
Liangliang Jiang
Jiarong Chen
Qiuli Li
Jing Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.1001239

3,631 views
13 citations

Original Research

Published on 08 Nov 2022

Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value

in Cancer Genetics and Oncogenomics

Danke Wang
Jiacheng Dai
Chen Suo
Shangzi Wang
Yuting Zhang
Xingdong Chen

Frontiers in Genetics

doi 10.3389/fgene.2022.1033214

3,255 views
4 citations

Original Research

Published on 08 Nov 2022

The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy

in Cancer Genetics and Oncogenomics

Jie Cheng
Qianyuan Li
Sheng Xiao
Lu Nie
Jianping Liao
Qingjie Jiang
Biyu Xiang
Hongfei Zhang
Yanhong Jiang
Chenjiao Yao

Frontiers in Genetics

doi 10.3389/fgene.2022.1047326

1,728 views
4 citations

Original Research

Published on 07 Nov 2022

A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Wencong Ding
Biyi Li
Yuan Zhang
Liu He
Junwei Su

Frontiers in Genetics

doi 10.3389/fgene.2022.1047231

2,663 views
12 citations

Original Research

Published on 07 Nov 2022

TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer

in Cancer Genetics and Oncogenomics

Xiong Zou
Yi Guo
Zengnan Mo

Frontiers in Genetics

doi 10.3389/fgene.2022.905988

2,168 views
7 citations

Original Research

Published on 03 Nov 2022

Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses

in Cancer Genetics and Oncogenomics

Jiawei Zeng
Honglin Tan
Bin Huang
Qian Zhou
Qi Ke
Yan Dai
Jie Tang
Bei Xu
Jiafu Feng
Lin Yu

Frontiers in Genetics

doi 10.3389/fgene.2022.959170

2,896 views
5 citations

Original Research

Published on 03 Nov 2022

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma

in Cancer Genetics and Oncogenomics

Peng Hong
Weichao Huang
Huifang Du
Ding Hu
Qingfei Cao
Yinjie Wang
Huashan Zhang
Siqiao Tong
Zizhi Li
Ming Tong

Frontiers in Genetics

doi 10.3389/fgene.2022.1009555

2,714 views
10 citations

Mini Review

Published on 03 Nov 2022

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach

in Cancer Genetics and Oncogenomics

Qiao Zhou
Ting Li
Qin Qin
Xiaobo Huang
Yi Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.1039951

4,565 views
6 citations

Original Research

Published on 03 Nov 2022

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Xueying Fang
Enmin Huang
Xiaopeng Xie
Kai Yang
Shuqian Wang
Xiaoqing Huang
Mei Song

Frontiers in Genetics

doi 10.3389/fgene.2022.951311

3,483 views
4 citations

Original Research

Published on 03 Nov 2022

High expression of TTC21A predicts unfavorable prognosis and immune infiltrates in clear cell renal cell carcinoma

in Cancer Genetics and Oncogenomics

Junhao Lin
DeYong Nong
Wei Wang
Xiaobin Guo
ChunLin Li
BingCai Li
Haojian Wang
Zhi Chen
XiMing Li
GuiHai Huang

Frontiers in Genetics

doi 10.3389/fgene.2022.967378

1,944 views
1 citation

Original Research

Published on 02 Nov 2022

A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study

in Cancer Genetics and Oncogenomics

Huihuang Li
Jiao Hu
Xiongbing Zu
Minfeng Chen
Jinbo Chen
Yihua Zou
Ruoping Deng
Gang Qin
Wenze Li
Jiansheng Tang

Frontiers in Genetics

doi 10.3389/fgene.2022.1047481

2,094 views

Original Research

Published on 02 Nov 2022

A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Junshang Dai
Yuwen Pan
Yili Chen
Shuzhong Yao

Frontiers in Genetics

doi 10.3389/fgene.2022.1024508

2,376 views
6 citations

Original Research

Published on 02 Nov 2022

A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators

in Cancer Genetics and Oncogenomics

Dan Pu
Dan Liu
Can Li
Chunyan Chen
Yuxin Che
Jiaoyan Lv
Yang Yang
Xuelian Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.933798

2,311 views
1 citation

Review

Published on 01 Nov 2022

The role of SELENBP1 and its epigenetic regulation in carcinogenic progression

in Cancer Genetics and Oncogenomics

Yue Zhang
Qing He

Frontiers in Genetics

doi 10.3389/fgene.2022.1027726

3,456 views
3 citations

Navigation group

Articles

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer

Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials

Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer

Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value

The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy

A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma

TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer

Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma

High expression of TTC21A predicts unfavorable prognosis and immune infiltrates in clear cell renal cell carcinoma

A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study

A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma

A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators

The role of SELENBP1 and its epigenetic regulation in carcinogenic progression